Search clinical trials for: Topical calcineurin inhibitors

Total 65903 results

Pfizer

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic

United States
Centre Hospitalier Departemental Vendee

Recruiting

Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients (GLITTER)

Kidney Failure, Chronic

France
Massachusetts General Hospital

Withdrawn

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

Alzheimer Disease | Mild Cognitive Impairment
The Third Xiangya Hospital of Central South University
Hunan Provincial People's Hospital; ZhuZhou Central Hospital; First People's...

Unknown

Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome (PISTONS)

Pharmacokinetics | Nephrotic Syndrome | Tacrolimus
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis

Dermatitis, Atopic

Vietnam
Astellas Pharma Inc

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Mayo Clinic

Completed

Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

Stem Cell Transplant | Immunosuppression | Bone Marrow Transplant

United States
Indonesia University

Active, not recruiting

Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Androgenetic Alopecia

Indonesia
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
University of Alabama at Birmingham

Active, not recruiting

Topical Chemoprevention of Skin Cancer Biomarkers

Non-melanoma Skin Cancer

United States
Medical University of Vienna
Astellas Pharma GmbH

Completed

Pain Thresholds Under High-dose Topical Capsaicin

Pain

Austria
Kenneth Hargreaves
U.S. Army Medical Research and Development Command; San Antonio Military Medical...

Withdrawn

Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent

Pain | Burns | Hyperalgesia | Thermal Injury

United States
Panag Pharma Inc.

Completed

Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee

Pain

Canada
Singapore General Hospital

Active, not recruiting

Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

Kidney Transplant Rejection | Kidney Transplant; Complications

Singapore
Seoul National University Hospital

Completed

a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients

Pharmacokinetics | Tacrolimus

Korea, Republic of
University of California, Davis

Withdrawn

Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

Atopic Dermatitis
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis

Dermatitis, Atopic

Vietnam
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG; Astellas Pharma Inc

Completed

TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

Kidney Transplantation

France
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
National Center for Research Resources (NCRR)

Completed

Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing

Kidney Transplantation

United States
University of Colorado, Denver
Pfizer

Active, not recruiting

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Vitiligo

United States
Biozeus Biopharmaceutical S.A.

Recruiting

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Erectile Dysfunction | Prostate Cancer | Radical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy

Brazil
Sandoz

Completed

Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat

Sore Throat

Russian Federation
Massachusetts General Hospital

Terminated

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Breast Cancer

United States
Chiesi Hungary Ltd.
Chiesi Slovenija, d.o.o.

Recruiting

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients (LTA)

Liver Failure

Hungary, Slovenia
UNC Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill

Completed

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Acute GVHD

United States
Seoul National University Hospital
Chong Kun Dang Pharmaceutical

Completed

Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

Nephrotic Syndrome

Korea, Republic of
Pontificia Universidad Catolica de Chile

Completed

Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors (FKosl)

Evidence of Liver Transplantation | Effects of Immunosuppressant Therapy

Chile
Seoul National University Hospital

Completed

Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome (MCNS)

Minimal Change Disease

Korea, Republic of
Maastricht University Medical Center

Unknown

Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients

Organ Transplantation

Netherlands
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Acne Vulgaris

United States, Belize
University of California, Los Angeles
Food and Drug Administration (FDA)

Completed

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

Renal Transplant Rejection

United States
University Hospital Heidelberg

Unknown

Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective Study

Liver Transplantation

Germany
Shandong University

Completed

Pharmacokinetics of Tacrolimus in Children

Nephrotic Syndrome
Rennes University Hospital

Completed

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE) (STABILE)

Biliary Concentration of Tacrolimus

France
Nantes University Hospital

Terminated

Protocol Calcineurin Inhibitor (CNI) Weaning

Function of Renal Transplant

France
University of Cincinnati
University of Colorado, Denver; Children's Hospital Medical Center, Cincinnati

Completed

Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients

Complication of Transplant

United States
Chinese University of Hong Kong

Completed

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

Lupus Erythematosus, Systemic | Lupus Nephritis

Hong Kong
Astellas Pharma Inc

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
Astellas Pharma Inc

Completed

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Lupus Nephritis

Japan
TWi Biotechnology, Inc.

Recruiting

Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare

Granuloma Annulare

United States
Karo Pharma AB

Completed

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Onychomycosis

Tunisia
Cosmetique Active International

Completed

Anti-aging Repairing Serum: Efficacy and Tolerability Study

Anti-aging

Brazil
Hanyang University
Korean Ministry of Food and Drug Safety; College of Pharmacy, Seoul National...

Completed

Observational Study to Assess Safety and Utility Pattern of Topical Steroids

Skin Diseases

Korea, Republic of
Centre for Human Drug Research, Netherlands
Maruho Co., Ltd.

Recruiting

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

Acne Vulgaris

Netherlands
Assiut University

Not yet recruiting

Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.

Alopecia Areata

Egypt
Radboud University Medical Center

Unknown

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Johnson & Johnson Healthcare Products Division...
Johnson & Johnson Consumer and Personal Products Worldwide

Completed

Clinical Trial in Females for Female Pattern Hair Loss

Androgenetic Alopecia

United States, United Kingdom, France, Germany
Odense University Hospital

Not yet recruiting

Topical Tacrolimus for Breast Cancer-related Lymphedema

Lymphedema

Denmark

3

Subscribe